Healthcare & Life Sciences
Spero
Russiaspero.ai
Spero is a Healthcare & Life Sciences startup based in Russia, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Spero
Based in Russia, Spero is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Spero provides a diagnostic service called SPERO-screen that analyzes hormonal blood tests and menstrual data to assess a woman's hormonal status and estimate the likelihood of conception during current and upcoming menstrual cycles.
Explore Spero's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.